These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8677841)

  • 1. Alpha blockers: a reassessment of their role in therapy.
    Cauffield JS; Gums JG; Curry RW
    Am Fam Physician; 1996 Jul; 54(1):263-6, 269-70. PubMed ID: 8677841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and CHD risk: whither alpha-1 blockers?
    Pandit RB
    Indian Heart J; 1996; 48(3):265-71. PubMed ID: 8755013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM
    Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxazosin: a new approach to hypertension and benign prostatic hyperplasia.
    Pool JL
    Br J Clin Pract; 1996; 50(3):154-63. PubMed ID: 8733335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New use for alpha blockers: benign prostatic hyperplasia.
    Hill SJ; Lawrence SL; Lepor H
    Am Fam Physician; 1994 Jun; 49(8):1885-8, 1893-4. PubMed ID: 7515555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding role of alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia.
    Kirby RS
    Int J Clin Pract; 1998 Sep; 52(6):402-7. PubMed ID: 9894377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
    Cheng TO
    Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha adrenergic receptor blockers for patients with hypertension].
    Iwatsubo K; Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():294-9. PubMed ID: 16981559
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha 1 blockers: antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignored.
    Waite MA
    J Intern Med Suppl; 1991; 735():113-7. PubMed ID: 1675053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
    Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New findings on the use of specific alpha-1 adrenergic blockers in the treatment of high blood pressure].
    Horký K
    Vnitr Lek; 1991 Jun; 37(6):604-11. PubMed ID: 1680257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: maximizing treatment with alpha blockers.
    Lowenthal DT; Flannery M; Mader SL; Nelson RP
    Geriatrics; 1998 Oct; 53 Suppl 2():S4-28. PubMed ID: 9789482
    [No Abstract]   [Full Text] [Related]  

  • 20. Q: Should alpha-blockers ever be used as antihypertensive drugs?
    Rossitto G; Kamath G; Messerli FH
    Cleve Clin J Med; 2010 Dec; 77(12):884-8. PubMed ID: 21147942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.